This tender with title A Laronidase (genetical recombination) (2.9mg 5ml×1vial/case) 2,025 cases,B Ravulizumab (genetical recombination) (300mg 3ml×1vial/case) 242 cases,C Ravulizumab (genetical recombination) (1100mg 11ml×1vial/case) 68 cases,D Inebili… - 2000621 has been published on Bidding Source portal dated 25 Jan 2026 for the country of Japan. It has been categorized on . For similar tenders you can see tenders mentioned below of this page.
For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now
Or Request a call back now and one of our representatives will contact you. Contact us